Display options
Cite
Ruiz-Sánchez E, Pedraza-Chaverri J, Medina-Campos ON, et al. S-allyl Cysteine, a Garlic Compound, Produces an Antidepressant-Like Effect and Exhibits Antioxidant Properties in Mice. Brain Sci. 2020;10(9)doi: 10.3390/brainsci10090592.
Ruiz-Sánchez, E., Pedraza-Chaverri, J., Medina-Campos, O. N., Maldonado, P. D., & Rojas, P. (2020). S-allyl Cysteine, a Garlic Compound, Produces an Antidepressant-Like Effect and Exhibits Antioxidant Properties in Mice. Brain sciences, 10(9), . https://doi.org/10.3390/brainsci10090592
Ruiz-Sánchez, Elizabeth, et al. "S-allyl Cysteine, a Garlic Compound, Produces an Antidepressant-Like Effect and Exhibits Antioxidant Properties in Mice." Brain sciences vol. 10,9 (2020). doi: https://doi.org/10.3390/brainsci10090592
Ruiz-Sánchez E, Pedraza-Chaverri J, Medina-Campos ON, Maldonado PD, Rojas P. S-allyl Cysteine, a Garlic Compound, Produces an Antidepressant-Like Effect and Exhibits Antioxidant Properties in Mice. Brain Sci. 2020 Aug 26;10(9). doi: 10.3390/brainsci10090592. PMID: 32859119; PMCID: PMC7564461.
Copy Download .nbib Format: NLM
Share it on

Brain Sci. 2020 Aug 26;10(9). doi: 10.3390/brainsci10090592.

S-allyl Cysteine, a Garlic Compound, Produces an Antidepressant-Like Effect and Exhibits Antioxidant Properties in Mice.

Brain sciences

Elizabeth Ruiz-Sánchez, José Pedraza-Chaverri, Omar N Medina-Campos, Perla D Maldonado, Patricia Rojas

Affiliations

  1. Laboratory of Neurotoxicology, National Institute of Neurology and Neurosurgery "Manuel Velasco Suárez", SS, Av. Insurgentes Sur No. 3877, Mexico City 14269, Mexico.
  2. Facultad de Química, Departamento de Biología, Universidad Nacional Autónoma de México, CDMX 04510, Mexico.
  3. Laboratory of Cerebral Vascular Pathology, National Institute of Neurology and Neurosurgery "Manuel Velasco Suárez", SS, Av. Insurgentes Sur No. 3877, Mexico City 14269, Mexico.

PMID: 32859119 PMCID: PMC7564461 DOI: 10.3390/brainsci10090592

Abstract

Depression is a psychiatric disorder, and oxidative stress is a significant mechanism of damage in this mood disorder. It is characterized by an enhancement of oxidative stress markers and low concentrations of endogenous antioxidants, or antioxidants enzymes. This suggests that antioxidants could have an antidepressant effect. S-allyl cysteine (SAC) is a compound with antioxidant action or free radical scavenger capacity. The purpose of the current research was to evaluate the antidepressant-like effect as well as the antioxidant role of SAC on a preclinical test, using the Porsolt forced swim test (FST). SAC (30, 70, 120, or 250 mg/kg, ip) was administered to male BALB/c mice daily for 17 days, followed by the FST at day 18. Oxidative stress markers (reactive oxygen species, superoxide production, lipid peroxidation, and antioxidant enzymes activities) were analyzed in the midbrain, prefrontal cortex, and hippocampus. SAC (120 mg/kg) attenuated the immobility scores (44%) in the FST, and protection was unrelated to changes in locomotor activity. This antidepressant-like effect was related to decreased oxidative stress, as indicated by lipid peroxidation and manganese-superoxide dismutase (Mn-SOD) activity in the hippocampus. SAC exerts an antidepressant-like effect that correlated, in part, with preventing oxidative damage in hippocampus.

Keywords: Porsolt forced swim test; S-allyl cysteine; antidepressant-like effect; antioxidant defense; antioxidant enzymes; oxidative stress

References

  1. Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):12138-43 - PubMed
  2. Oxid Med Cell Longev. 2015;2015:898393 - PubMed
  3. Redox Rep. 2003;8(6):365-70 - PubMed
  4. Acta Neurobiol Exp (Wars). 2019;79(3):232-237 - PubMed
  5. Evid Based Complement Alternat Med. 2015;2015:328545 - PubMed
  6. J Neurosci. 2001 Jul 1;21(13):4822-9 - PubMed
  7. Annu Rev Public Health. 2013;34:119-38 - PubMed
  8. Nature. 1977 Apr 21;266(5604):730-2 - PubMed
  9. J Affect Disord. 2007 Jan;97(1-3):23-35 - PubMed
  10. Psychiatry Res. 2018 Apr;262:566-574 - PubMed
  11. Mol Metab. 2018 Jun;12:113-121 - PubMed
  12. Curr Neuropharmacol. 2014 Mar;12(2):108-19 - PubMed
  13. Curr Med Chem. 2011;18(22):3306-13 - PubMed
  14. Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):11336-11341 - PubMed
  15. Hum Psychopharmacol. 2009 Jun;24(4):277-86 - PubMed
  16. Basic Clin Pharmacol Toxicol. 2005 Oct;97(4):218-21 - PubMed
  17. Eur J Pharmacol. 2016 Aug 5;784:192-8 - PubMed
  18. Curr Drug Targets. 2014;15(13):1177-99 - PubMed
  19. Nutr Res. 2020 Jan;73:1-14 - PubMed
  20. Neuron. 2013 Jul 10;79(1):16-29 - PubMed
  21. Am J Physiol Renal Physiol. 2005 Jun;288(6):F1144-52 - PubMed
  22. Glia. 1998 Oct;24(2):252-6 - PubMed
  23. Psychoneuroendocrinology. 2017 Feb;76:197-205 - PubMed
  24. Glia. 2000 Jan 1;29(1):25-34 - PubMed
  25. PLoS One. 2009;4(1):e4330 - PubMed
  26. Psychopharmacology (Berl). 2005 Jan;177(3):245-55 - PubMed
  27. Hum Psychopharmacol. 2007 Mar;22(2):67-73 - PubMed
  28. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):676-92 - PubMed
  29. J Nutr. 2001 Mar;131(3s):1100S-5S - PubMed
  30. Oxid Med Cell Longev. 2012;2012:609421 - PubMed
  31. Nat Rev Neurosci. 2017 Jun;18(6):335-346 - PubMed
  32. J Phys Chem B. 2011 Nov 17;115(45):13408-17 - PubMed
  33. Neuroscience. 1994 Jul;61(2):317-30 - PubMed
  34. J Affect Disord. 2010 Sep;125(1-3):287-94 - PubMed
  35. Mol Psychiatry. 2007 Aug;12(8):756-66 - PubMed
  36. Neural Plast. 2017;2017:6871089 - PubMed
  37. Front Psychiatry. 2014 Jan 22;5:5 - PubMed
  38. Molecules. 2018 Aug 30;23(9): - PubMed
  39. Oxid Med Cell Longev. 2012;2012:907162 - PubMed
  40. Nutr Rev. 2012 May;70(5):257-65 - PubMed
  41. Nitric Oxide. 1997 Apr;1(2):145-57 - PubMed
  42. Eur J Neurosci. 2008 Jul;28(1):41-50 - PubMed
  43. J Pharmacol Exp Ther. 2003 Aug;306(2):734-43 - PubMed
  44. J Ethnopharmacol. 2006 Dec 6;108(3):385-94 - PubMed
  45. Neurochem Int. 2011 Oct;59(5):628-36 - PubMed
  46. J Nutr Biochem. 2011 Oct;22(10):937-44 - PubMed
  47. Am J Pathol. 1996 Jan;148(1):273-9 - PubMed

Publication Types

Grant support